All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections

ABSTRACT Invasive infections with emerging yeasts such as Geotrichum, Saprochaete/Magnusiomyces, Trichosporon, and other species are associated with high morbidity and mortality rates. Due to the rarity and heterogeneity of these yeasts, medical mycology has lacked guidance in critical areas affecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rosanne Sprute, Oliver A. Cornely, Sharon C.-A. Chen, Danila Seidel, Audrey N. Schuetz, Sean X. Zhang
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/35aaa1f5ba104608a55e64fe3bd1dca4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:35aaa1f5ba104608a55e64fe3bd1dca4
record_format dspace
spelling oai:doaj.org-article:35aaa1f5ba104608a55e64fe3bd1dca42021-11-10T18:37:52ZAll You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections10.1128/mBio.01594-212150-7511https://doaj.org/article/35aaa1f5ba104608a55e64fe3bd1dca42021-08-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01594-21https://doaj.org/toc/2150-7511ABSTRACT Invasive infections with emerging yeasts such as Geotrichum, Saprochaete/Magnusiomyces, Trichosporon, and other species are associated with high morbidity and mortality rates. Due to the rarity and heterogeneity of these yeasts, medical mycology has lacked guidance in critical areas affecting patient management. Now, physicians and life scientists from multiple disciplines and all world regions have united their expertise to create the “Global guideline for the diagnosis and management of rare yeast infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.” Recommendations are stratified for high- and low-resource settings and are therefore applicable worldwide. The advantages and disadvantages of various diagnostic methods and treatment options are outlined. This guideline reflects the current best-practice management for invasive rare yeast infections in a range of settings, with the intent of establishing a global standard of care for laboratorians and clinicians alike.Rosanne SpruteOliver A. CornelySharon C.-A. ChenDanila SeidelAudrey N. SchuetzSean X. ZhangAmerican Society for MicrobiologyarticleMalasseziaPseudozymaRhodotorulaantifungal therapyinvasive fungal infectioninvasive microorganismsMicrobiologyQR1-502ENmBio, Vol 12, Iss 4 (2021)
institution DOAJ
collection DOAJ
language EN
topic Malassezia
Pseudozyma
Rhodotorula
antifungal therapy
invasive fungal infection
invasive microorganisms
Microbiology
QR1-502
spellingShingle Malassezia
Pseudozyma
Rhodotorula
antifungal therapy
invasive fungal infection
invasive microorganisms
Microbiology
QR1-502
Rosanne Sprute
Oliver A. Cornely
Sharon C.-A. Chen
Danila Seidel
Audrey N. Schuetz
Sean X. Zhang
All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
description ABSTRACT Invasive infections with emerging yeasts such as Geotrichum, Saprochaete/Magnusiomyces, Trichosporon, and other species are associated with high morbidity and mortality rates. Due to the rarity and heterogeneity of these yeasts, medical mycology has lacked guidance in critical areas affecting patient management. Now, physicians and life scientists from multiple disciplines and all world regions have united their expertise to create the “Global guideline for the diagnosis and management of rare yeast infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.” Recommendations are stratified for high- and low-resource settings and are therefore applicable worldwide. The advantages and disadvantages of various diagnostic methods and treatment options are outlined. This guideline reflects the current best-practice management for invasive rare yeast infections in a range of settings, with the intent of establishing a global standard of care for laboratorians and clinicians alike.
format article
author Rosanne Sprute
Oliver A. Cornely
Sharon C.-A. Chen
Danila Seidel
Audrey N. Schuetz
Sean X. Zhang
author_facet Rosanne Sprute
Oliver A. Cornely
Sharon C.-A. Chen
Danila Seidel
Audrey N. Schuetz
Sean X. Zhang
author_sort Rosanne Sprute
title All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
title_short All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
title_full All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
title_fullStr All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
title_full_unstemmed All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
title_sort all you need to know and more about the diagnosis and management of rare yeast infections
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/35aaa1f5ba104608a55e64fe3bd1dca4
work_keys_str_mv AT rosannesprute allyouneedtoknowandmoreaboutthediagnosisandmanagementofrareyeastinfections
AT oliveracornely allyouneedtoknowandmoreaboutthediagnosisandmanagementofrareyeastinfections
AT sharoncachen allyouneedtoknowandmoreaboutthediagnosisandmanagementofrareyeastinfections
AT danilaseidel allyouneedtoknowandmoreaboutthediagnosisandmanagementofrareyeastinfections
AT audreynschuetz allyouneedtoknowandmoreaboutthediagnosisandmanagementofrareyeastinfections
AT seanxzhang allyouneedtoknowandmoreaboutthediagnosisandmanagementofrareyeastinfections
_version_ 1718439766922362880